MUC16 and ovarian carcinoma: CA125-Tn could be a novel biomarker for peritoneal dissemination and a promising predictor of surgical completeness in ovarian cancer that could help surgeons adopt optimized treatment strategies for patients with advanced ovarian cancer as a pre-treatment evaluator.